BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Introducing X-MAN – The Model Cancer Patient - Dr Darrin Disley\
 , (1991-96 PhD Biotechnology)\, Executive Chairman of Horizon Discovery Lt
 d and Director of New Ventures of Execute Technologies
DTSTART:20101126T170000Z
DTEND:20101126T180000Z
UID:TALK27987@talks.cam.ac.uk
CONTACT:21317
DESCRIPTION:This proprietary virally-mediated human gene-editing technolog
 y enables any endogenous gene in a human cell-line to be altered quickly\,
  reliably and without introducing unwanted and \nconfounding genotypes and
 /or phenotypes.  X-MAN cell lines \naccurately model the disease-causing m
 utations observed in cancer patients and are being used by academic and in
 dustry leaders to identify the effect of individual mutations on drug acti
 vity\, patient responsiveness and resistance\, and to successfully predict
  which patient sub-groups will respond to currently-available and future d
 rug treatments. The findings from the company’s scientific founders and 
 advisors are defining how targeted colorectal cancer drugs are developed a
 nd prescribed.\n
LOCATION:Dept Chemical Engineering and Biotechnology\, New Museums Site\, 
 Pembroke Street\, CB2 3RA
END:VEVENT
END:VCALENDAR